Early features in the pathogenesis of atherosclerosis include accumulation of oxidized LDL (oxLDL) and endothelial expression of the vascular adhesion molecule VCAM-1. 
Introduction
Early features in the pathogenesis of atherosclerosis include accumulation of oxidized LDL (oxLDL) and endothelial expression of the vascular adhesion molecule VCAM-1. Because antioxidants inhibit endothelial VCAM-1 expression, we tested the hypothesis that oxLDL functions as a prooxidant signal in atherogenesis to augment VCAM-1 activation by inflammatory signals. Cultured human aortic endothelial cells (HAECs) or human umbilical vein endothelial cells (HUVECs) were incubated with unmodified LDL, oxLDL, or glycated LDL for 48 h. No change in VCAM-1, intercellular cell adhesion molecule-1 (ICAM-1), or E-selectin expression from control was observed by ELISA. However, doseresponse and time course studies demonstrated that oxLDL enhanced VCAM-1 expression induced by the cytokine tumor necrosis factor a (TNFa) 63% in HAECs and 45% in HUVECs over unmodified LDL or control. Using flow cytometry analysis, oxLDL augmented TNFa-induced VCAM-1 expression in a uniform HAEC population. oxLDL had no effect on E-selectin induction. oxLDL augmented TNFa-induced ICAM-1 expression 44% in HAECs but not in HUVECs. Glycated LDL augmented TNFa-induced VCAM-1 expression 35% in HAECs but not HUVECs. Similar results were obtained with 13-HPODE or lysophosphatidylcholine, significant components of oxLDL. 13-HPODE augmented TNFa-induced mRNA accumulation and transcriptional activation of VCAM-1 in HAECs. These results suggest that as long-term regulatory signals, specific oxidized fatty acid and phospholipid components of oxLDL augment the ability of vascular endothelial cells to express cytokine-mediated VCAM-1. These studies link oxidant signals conferred by oxLDL to oxidation-sensitive regulatory mechanisms controlling the expression of endothelial cell adhesion molecules involved in early atherosclerosis. (J. Clin. Invest. 1995. 95:1262-1270.) Key words: lipoprotein X fatty acid hydroperoxide -adhesion * oxidation * endothelium Several lines of evidence point to the key role of inflammatory processes in the pathogenesis of atherosclerosis (1) (2) (3) (4) (5) (6) . It has been shown that endothelial cell activation, by cytokines and other inflammatory mediators, results in the synthesis of binding molecules and chemotactic factors and increases interactions with leukocytes (7) (8) (9) (10) (11) . Endothelial cells play a major role in defining the types of leukocytes recruited, such as monocytes, lymphocytes, or neutrophils, by selectively expressing specific adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-1 ), intercellular adhesion molecule-I (ICAM-1), or E-selectin, in response to various inflammatory stimuli (12) (13) (14) . The adhesion of leukocytes is believed to be based on a cascade of molecular interactions and is mediated by multiple cell adhesion molecules (10, 15) .
Modulation of the expression and function of vascular genes by oxidative signals may be an important mechanism through which inflammatory signals initiate and propagate atherosclerosis. Endothelial expression of the cell surface adhesion molecule VCAM-1 is an early, inducible event in experimental models of atherogenesis preceding the accumulation of inflammatory mononuclear leukocytes (16) . Consistent with the notion that oxidative stress plays an important role in atherogenesis, activation of endothelial VCAM-1 gene expression by diverse inflammatory signals occurs through an antioxidant-inhibitable mechanism that involves a reduction-oxidation (redox) -sensitive activation of an NF-KB-like transcription factor (13) . This mode of regulation distinguishes VCAM-1 from other inducible adhesion molecules, such as ICAM-1 and E-selectin (13) , and suggests that VCAM-1 may represent a useful experimental paradigm to explore the linkage between oxidative modulatory signals and nuclear regulatory mechanisms in the vasculature.
Oxidatively modified LDL (oxLDL) has been implicated as an important oxidative signal in the pathogenesis of atherosclerosis. oxLDL accumulates and is preferentially synthesized at sites of the vascular wall predisposed to atherosclerosis (17, 18) . Although its precise mechanism of formation is not known, LDL may be modified through lipid peroxidation in the formation of fatty acid hydroperoxides (19, 20) , resulting in novel epitopes generated on oxLDL that are recognized by macrophage "scavenger" receptors (19) . Though still controversial, cellular lipoxygenases may mediate LDL oxidation in several cell types: LDL treated with soybean lipoxygenase and phospholipase A2 closely resembles oxLDL (21) . It has also been shown that there are higher levels of 15-lipoxygenase enzymatic activity in atherosclerotic lesions of rabbit and human aorta than in corresponding normal arteries (22, 23) . Other modifications, such as glycated LDL (the nonenzymatic binding of glucose to LDL observed primarily in diabetes mellitus), may be predisposed to further oxidization (24) . Recently, Richardson et al. (25) have demonstrated that there is increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits, providing at least a partial mechanism for the enhanced atherosclerosis associated with diabetes mellitus (26, 27) .
oxLDL exhibits a wide variety of potentially atherogenic properties in vitro, including stimulation of monocyte migration (28) and inhibition of endothelium-dependent vasodilatation (29, 30 50 ag/ml endothelial cell growth supplement, 25 mM Hepes buffer, 2 mM L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin. Human aortic endothelial cells (HAECs), also purchased from Clonetics, Inc., were cultured in M199 medium supplemented with 10 ng/ml endothelial cell growth supplement, 15% FBS, 10 Mg/ml hydrocortisone, and 2 mM L-glutamine. Cells were grown at 37°C on tissue culture plates and used for experimentation at no greater than passage 8. HUVECs were grown on plates specially coated with 0.1% gelatin.
Preparation of LDL Human LDL (d 1.019-1.063 g/ml) was isolated from EDTA-treated plasma by density gradient centrifugation and pooled; the solvent density was adjusted to 1.020 by a high density salt solution containing KBr, NaCl, and EDTA. Ultracentrifugation was performed for 18 h at 50,000 rpm in a 50.2 rotor. The supernatant was collected and dialyzed extensively against isotonic saline and 0.5 mM EDTA (32) . The LDL supernatant was again ultracentrifuged for 18 h at 50,000 rpm in a 50.2 rotor. The supernatant LDL was collected and dialyzed extensively against isotonic saline and 0.5 mM EDTA. Oxidation of LDL was performed by dialysis against EDTA-free isotonic saline supplemented with 4 MM CuSO4 at 37°C for 18 h. Glycation of LDL was performed by techniques described by Schleicher et al. (33) . All LDL preparations were stored in PBS. The extent of oxidation of the LDL preparations was measured by the thiobarbituric acid reactivity assay as described previously (34 Effect of hydroperoxide and lyso-PC formation on cell surface expression of adhesion molecules. HAECs in M199 medium were plated in 96-well plates, as previously described. Linoleic acid, purchased from Cayman Chemical (Ann Arbor, MI), was converted to linoleyl hydroperoxide (13-HPODE) via the addition of 15-lipoxygenase (17, 38) . Additionally, a preparation of 13-HPODE was purchased commercially from Cayman Chemical. No appreciable differences in biological effects were seen in these two separate preparations. The preparation was added to HAECs (final concentration, 30 MM) and incubated for a 48-h period.
lyso-PC (50MM), purchased from Calbiochem-Behring Corp. (La Jolla, CA), was added to HAECs for a 48-h period. The cells were then exposed to TNFa at doses of 10, 25, 50, and 100 U/ml for a 6-h period at 37°C. Cells were then removed from the tissue culture incubator and prepared for ELISA of VCAM-1, ICAM-1, and/or E-selectin cell surface expression.
ELISA of cell adhesion molecule expression. HUVECs and HAECs were plated on 96-well tissue culture plates. Primary antibodies in M199 medium with 5% FBS were added to each well and incubated for 30 min at 37°C. The cells were then washed and incubated for 30 min with peroxidase conjugated with goat anti-mouse IgG (Bio-Rad Laboratories, Richmond, CA) diluted 1:500 in M199 medium with 5% FBS.
The wells were then washed, and the binding of antibody was detected by the addition of 100 MI of 0.1 mg/ml 3,3',5,5'-tetramethylbenzidine (Sigma Chemical Co., St. Louis, MO) with 0.003% hydrogen peroxide.
The reaction was stopped by the addition of 25 MI of 8 N sulfuric acid.
Plates were read on an ELISA reader (Bio-Rad Laboratories, Hercules, CA) at OD 450 nm after blanking on rows stained only with second step antibody. All data points were performed at least in triplicate.
Fluorescence immunoassay. Confluent HAECs in 150-mm2 plates were treated in M199 medium with 13-HPODE (30 iMM) and oxLDL (100 Mg/ml) at 37°C for 48 h. HAECs were then treated or not with TNFa (100 U/ml) for 6 h. At the end of the incubation, the cells were washed with M199 medium and incubated on ice for 1 h with mAb against human VCAM-1 (Southern Biotechnology, Birmingham, AL).
Subsequently, HAECs were washed three times with PBS and then incubated on ice for 1 h with FITC-conjugated anti-mouse IgG antibody (Southern Biotechnology). After washing four times with PBS, the cells were lysed with 0.01% (wt/vol) NaOH, 0.1% SDS buffer for 30 min at room temperature. The fluorescence of the cell lysate was determined with emission maximum at 520 nm and excitation at 488 nm, using a fluorescence spectrophotometer (Becton-Dickinson, San Jose, CA). Specific cell surface mAb binding in this assay was calculated by subtracting the fluorescence detected in endothelial cell monolayers incubated in the absence of primary mAb (39) .
Northern blot analysis. Total cellular RNA was isolated by a single extraction using acid guanidinium thiocyanate-phenol-chloroform (40) . Total cellular RNA (20 pg) was size fractionated using 1% agarose-formaldehyde gels in the presence of 1 Mg/ml ethidium bromide.
Transfers of RNA and hybridizations were performed as described previously (13) . After hybridization, filters were washed at a final stringency of 0.2x SSC (lx is 150 mM NaCl, 15 mM sodium citrate) at 55°C. Autoradiography was performed with an intensifying screen at -70°C. Laser densitometry and digital analysis of scanned images were used for quantitation of autoradiograms.
Transcriptional analysis. Early passaged HAECs in 150-mm2 culture dishes were treated with linoleic acid (30 ,M) or 13-HPODE (30 ,uM) for 48 h and then exposed to TNFa (100 U/mi) for 3 h. Nuclei were prepared, and transcriptional rates were determined by nuclear run-off analysis as previously described (41 Modified LDLs did effect a significant change in cytokine induction of VCAM-1 gene expression in both HUVECs and HAECs. As shown in Fig. 1 , preincubation with native LDL at 100 ,ug/ml for 48 h (striped boxes, lanes 4 and 12) had no effect on the ability of TNFa alone (6-h exposure; lanes 2 and 10) (100 U/ml) to induce VCAM-1, E-selectin, or ICAM-1 expression in either cell type. However, preincubation with oxLDL augmented TNFa induction of VCAM-1 expression an additional 45% (P < 0.05), (Fig. 1 A, lane 6 ) and 64% (P < 0.05) (Fig. 1 B, lane 14) in both HUVECs and HAECs, respectively. In contrast, oxLDL had no effect on TNFa induction of E-selectin expression in either cell type ( Fig. 1 E and  F, lanes 6 and 14) or ICAM-l expression in HUVEs (C, lane 5). oxLDL did augment TNFa activation of ICAM-1 expression in HAECs by 36% (Fig. 1 D, lane 14) . Glycated LDL augmented TNFa activation of VCAM-1 expression in HAECs by 35% (P < 0.05) (Fig. 1 B, lane 16) but not in HUVECs, nor did it affect ICAM-1 or E-selectin expression in either cell type.
To explore further the augmentation of modified LDL on VCAM-1 gene expression, control and preincubated HAECs were exposed to TNFa (100 U/ml) for varying times up to 24 h and then assayed for cell surface VCAM-1 expression by ELISA. As shown in Fig. 2 Fig. 3 , preincubation alone (closed boxes) with unmodified linoleic acid (lane 3), 13-HPODE (lane 5), or oxLDL (lane 7) had no effect on cell surface expression of VCAM-1 (A), ICAM-1 (B), or Eselectin (C), as determined by ELISA in HAECs. Preincubation with linoleic acid had no effect of the ability of TNFa alone (6-h exposure; Fig. 3 , lanes 2 and 4) (100 U/ml) to induce VCAM-1, E-selectin, or ICAM-1 expression. However, preincubation with either 13-HPODE (Fig. 3, lane 6) or oxLDL (lane 8) augmented TNFa activation of both VCAM-1 (A) by 71% and 65%, respectively, and ICAM-1 (B) by 80% and 43%, respectively, but had no effect on E-selectin expression (C). Under identical experimental conditions, using flow cytometry analysis in HAECs, augmented expression of VCAM-I by both oxLDL and 13-HPODE occurred uniformly throughout the cell population rather than in a subpopulation of cells (Fig. 4, A-D) . This similarity between the effects of oxLDL and 13-HPODE on adhesion molecule expression suggests that a fatty acid hydroperoxide, such as 13 Fig. 5 , 13-HPODE enhanced inducible VCAM-1 (A) and ICAM-1 (B) gene expression over a wide range of TNFa concentrations (10-100 U/ml) but had no effect on Eselectin gene expression (C). This suggests that 13-HPODE Figure 1 . Effect of long-term exposure to modified LDL on TNFa regulation of endothelium-mediated cell adhesion molecule expression. HUVECs (A, C, and E) and HAECs (B, D, and F) were plated in 96-well plates, as described in Methods. Cells were incubated for 48 h with no LDL (Control, lanes 1, 2, 9, and 10), or with 100 ,ug/ml native LDL (lanes 3, 4, 11, and 12), oxLDL (lanes 5, 6, 13, and 14), or glycated LDL (lanes 7, 8, 15, and 16 ). Cells were then exposed (striped) or not (filled) to TNFa (100 U/ml) for a 6-h period. HAECs were exposed to TNFa (100 U/ml). The cells were assayed for cell surface VCAM-1 by ELISA, as described in Methods. Values presented are the means for five separate experiments performed in triplicate. An asterisk indicates that the value differs (P < 0.05) from control at its corresponding time point.
HPODE, lyso-PC augmented TNFa-activated VCAM-l expression at lower TNFa concentrations (up to 25 U/ml) (Fig. 5 A) and had no effect on E-selectin expression (C). However, in contrast to 13-HPODE, lyso-PC had no effect on VCAM-1 expression at higher TNFa concentrations; nor did it augment ICAM-1 expression. These results suggest that although 13-HPODE and lyso-PC mediate distinct pattems of regulation of cell adhesion molecule expression in HAECs, they share the common feature of augmenting cytokine-activated VCAM-1 gene expression.
13-HPODE augments TNFa-induced VCAM-1 gene expression at the mRNA level. To explore whether the augmentation of cytokine-induced VCAM-1 with 13-HPODE is observed at the mRNA level, HAECs were incubated with linoleic acid or 13-HPODE and then exposed to TNFa (100 U/ml) for 4 h. As shown in Fig. 6, 13 50 ItM lyso-PC for 48 h, as described in Methods. HAECs were exposed to differing concentrations of TNFa ( 10, 25, 50, and 100 U/ml) for a period of 6 h. Cell surface expression of (A) VCAM-1, (B) ICAM-1, and (C) E-selectin was determined by ELISA as described in Methods. Values presented are the means for three experiments performed in triplicate. An asterisk indicates that the value differs (P < 0.05) from control at its corresponding dose of TNFa.
interacting regulatory signals. A common feature underlying these complex regulatory interactions may involve redox-sensitive nuclear regulatory factors that modulate the expression of gene products such as the endothelial adhesion molecule VCAM-1 (13) . Using this molecular model, we esis, might function at least in part through modulation of redoxsensitive VCAM-1 gene expression. In this study, we have established that long-term exposure to either oxLDL or the fatty acid hydroperoxide (13-HPODE) and phospholipid (lyso-PC) components of oxLDL augments the ability of vascular endothelial cells from different vascular beds to express VCAM-1 in response to a cytokine inflammatory signal. These findings support the notion that naturally occurring oxidant signals may sensitize the vasculature to inflammatory signals through modulation of endothelial adhesion molecule gene expression.
Oxidative modification of LDL is an important early event in atherogenesis (18) . Most studies have focused on the role of oxLDL alone as a primary regulator of cellular function and gene expression (17, 18) , whereas little is known of the role of oxLDL in modulating the response of endothelial cells to other important factors resident in the atherosclerotic plaque, such as cytokines (42) . We have established that long-term exposure to oxLDL (48 h) (20) .
We also established that long-term exposure to another form of modified LDL, glycated LDL, appears to function in a manner analogous to oxLDL by augmenting cytokine activation of endothelial cell VCAM-1 gene expression. Glycated LDL is a modified form of LDL found in the serum of patients with diabetes mellitus (24) . Uptake and metabolism of the glycated LDL particle by endothelial cells may be distinct from that of oxLDL and may, through distinct, intracellular mechanisms, modulate expression of cell surface VCAM-1. Nevertheless, this observation suggests a possible functional link between vascular inflammatory processes, atherosclerosis, and diabetes mellitus. It may be that nonenzymatic glycation of proteins, by its association with cytokines and/or endothelial cells, either directly or indirectly induces the expression of genes encoding these cell adhesion molecules (25) .
The blood vessel origin of the endothelial cell appears to play a role in the response to the modulatory effect of oxLDL on adhesion molecule expression. Although oxLDL enhanced cytokine activation of VCAM-1 expression in both HUVECs and HAECs, ICAM-1 expression was similarly enhanced only in HAECs. In addition, and although only semiquantitative, there was a somewhat larger increase in VCAM-1 cell surface expression induced by TNFa in HAECs compared with HUVECs when exposed to oxidized and glycated LDL. These differences are not surprising, as considerable differences in functional and regulatory properties characterize endothelial cells derived from different vascular beds in culture, as well as intact vessels in vivo (31) . In our studies, this suggests that arterialderived endothelial cells such as HAECs may be more sensitive to extracellular oxidative signals than venous-derived HUVECs. Possible differences in the intrinsic redox properties of cell growth and medium conditions could also play a role and are currently being investigated. Additional factors, such as tissuespecific transcriptional regulatory factors, may also be important in regulating the extent of cell adhesion molecule gene expression.
A major outstanding issue concerning the role of oxLDL in atherogenesis focuses on the nature of the active chemical moiety(ies) that mediate its functional and regulatory properties. oxLDL is a complex molecule that contains several distinct biochemical moieties, each of which has been implicated in the atherosclerotic process (18) (19) (20) . The chemical structure of oxLDL generated within the vessel wall in vivo may not be precisely replicated by the wide variety of in vitro modification techniques used (43) (44) (45) , thus complicating a comparison of in vitro study results. Although their relative abundance may vary greatly, fatty acid hydroperoxides (notably 13-HPODE) and lyso-PC are consistently observed components of oxLDL (23) . We have established that oxLDL and its constituents 13-HPODE and lyso-PC share the common property of augmenting TNFa-activated VCAM-1 gene expression. However, two distinct patterns of regulation are apparent. First, both oxLDL and 13-HPODE enhance VCAM-1 expression at low (< 25 U/ml) and high (> 50 U/ml) levels of TNFa (23, 45, 47) . In the context of VCAM-l expression, fatty acid peroxides may also potentially serve as part of an intracellular, oxidation-sensitive signal transduction system controlling VCAM-1 expression. Through conversion of the major cellular reducing agent, glutathione, to oxidized glutathione, fatty acid hydroperoxides are normally detoxified by the enzyme, glutathione peroxidase (48) . Dithiocarbamates, such as diethyldithiocarbamate and pyrrolidine dithiocarbamate, act as inducers of glutathione peroxidase activity and prevent not only the decrease in glutathione peroxidase activity, but also the decrease in reduced/oxidized glutathione ratio observed in cells challenged with phorbol esters (49) . Through conversion of fatty acid hydroperoxides to non-hydroperoxide-containing compounds, these antioxidants may modulate VCAM-I gene expression. Although not directly tested, our studies would suggest that the generation of a fatty acid hydroperoxide, such as 13-HPODE, may serve as a second messenger signal in cytokine-mediated VCAM-1 gene expression. A direct role for 13-HPODE on VCAM-1 transactivation and NF-KB activation is now under study.
Our findings suggest that the degree to which 13-HPODE and lyso-PC are generated within the LDL molecule may underlie some of the heterogeneity observed in some of the biological effects of LDL modified by different in vitro oxidation techniques (3, 31 ) . For example, recent investigations have shown that minimally modified LDL activates cultured endothelial cells to increase their interaction with monocytes but not neutrophils (42, 49) . In the same study, copper-oxidized LDL demonstrated relatively minimal activity. Additionally, minimally modified LDL stimulates production of monocyte chemotactic protein-l in cells (49) , whereas the effect of metal-oxidized LDL is less pronounced (50) . It is interesting that minimally modified LDL is produced in vitro using soybean lipoxygenase and phospholipase A2. It is possible that the 13-HPODE (synthesized via lipoxygenase as well) that we used in our experiments might function as a biologically active component of minimally modified LDL when presented to the endothelial cell in vivo.
In summary, our findings demonstrate that the ability of endothelial cells to express specific cell surface adhesion molecules in response to a cytokine signal may be modulated by a naturally occurring oxidant signal, oxLDL, and its significant components, 13-HPODE and lyso-PC. The molecular mechanisms underlying the preferential response of VCAM-1, regardless of endothelial cell type, may be a function of its distinctive, redox-sensitive mode of regulation ( 13) . The mechanisms regulating ICAM-l expression are less clear but may involve tissuespecific factors, whereas E-selectin gene expression does not appear to be modulated by these natural oxidants. As the type of inflammatory response in vascular diseases such as atherosclerosis is defined at least in part by the types of cell adhesion molecules expressed by activated endothelial cells, differential regulation of these genes by oxidant signals may underlie the characteristic pattern of inflammation observed in this disease state.
